1. Introduction {#sec1}
===============

Systemic lupus erythematosus (SLE) represents a universal type of autoimmune rheumatic diseases. It is featured as the dysfunction of T cell response and B cell activation that leads to the generation of immune complexes in a variety of organs and tissues, which predominantly occurs in young and middle-aged females \[[@B1], [@B2]\]. In Asians, the SLE incidence was larger than that in European populations, with the gender ratio of 9 : 1 (female : male) \[[@B3], [@B4]\]. The detailed mechanism of SLE remains elusive. A previous report indicated that genetic predisposition and environmental and hormonal factors participated in the pathogenesis of SLE \[[@B5]\]. Likewise, accumulative evidence highlighted the significance of genetic factors to the susceptibility to SLE \[[@B6], [@B7]\].

Interleukin-33 (IL-33), as a newly discovered cytokine, is characterized as the member of IL-1 family. It has been reported to exert multiple biological functions, including chronic inflammation and autoimmune disease. The human IL-33 gene is located on chromosome 9 (9p24.1) \[[@B8]\]. Some studies suggested that the serum levels of IL-33 were remarkably upregulated in patients with Behcet\'s disease (BD), and IL-33 expression in skin tissue was notably higher in BD patients than in the normal individuals \[[@B9]\]. IL-33 was also found to function as the ligand of ST2, and the content in the serum was also associated with disease activity in SLE \[[@B10]\]. Previously, several articles unraveled the correlation between IL-33 gene polymorphisms and autoimmune diseases, such as ankylosing spondylitis, Behçet\'s disease, and lupus \[[@B11]--[@B13]\], and these studies all presented strong susceptibility. But to date, the association between IL-33 polymorphisms and SLE risk remains to be further determined. In addition, the occurrence and development of SLE were affected by not only genetic and environmental factors but also the interaction between the gene and environment. Our study is thus aimed at examining the role of IL-33 SNPs, as well as its interaction with the environment to the susceptibility to SLE in Chinese population.

2. Materials and Methods {#sec2}
========================

2.1. Subjects {#sec2.1}
-------------

The study sample consists of 846 participants, including 421 patients with SLE and 425 control participants, who were hospitalized in our hospital. All patients diagnosed with SLE were determined by a dermatologist. All SLE patients fulfilled the revised criteria for the diagnosis of SLE by the American College of Rheumatology (ACR) in 1997. Those participants were not included in the control group: (1) suffering from autoimmune diseases or having family history of autoimmune diseases and (2) suffering from critical diseases, including AID, cancer, and some inflammatory diseases. All the subjects enrolled were Han Chinese and they had no genetic relationship with each other. There were no significant differences of age and gender between patients and the control individuals. The index of disease activity was calculated based on the ACR SLE Disease Activity Index (SLEDAI). Informed consent was obtained from each participant.

2.2. Genomic DNA Extraction and Genotyping {#sec2.2}
------------------------------------------

Blood samples from all participants were acquired and treated with EDTA. Genomic DNA from participants was extracted by using the DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to standard procedures \[[@B14]\] and stored at -20°C for further use. The polymerase chain reaction (PCR) along with restriction fragment length polymorphism (RFLP) was performed for the genotyping of SNPs. The details of nucleotide sequence of primers and SNPs were shown in [Table 1](#tab1){ref-type="table"}. To confirm the genotyping results, sequencing was further conducted on PCR-amplified products.

2.3. Statistical Analysis {#sec2.3}
-------------------------

SPSS 20.0 software (SPSS Inc., IL, USA) was used for statistical analysis. Chi-squared test was analyzed whether the sex differences and the genotype distributions differed from the expected Hardy-Weinberg equilibrium (HWE) and the distribution of genotype and alleles between the SLE and healthy individuals. Data were expressed as mean ± standard deviation. Differences between two groups were compared using *t*-test. Odds ratios (OR) and corresponding 95% CIs were evaluated in the comparison of the genotypes and alleles in the groups of SLE and healthy individuals. The haplotype analysis was performed using PHASE 2.0 (University of Manchester, Manchester, UK). All analyses used the two-tailed estimation of significance. *P* \< 0.05 was considered statistically significant.

Generalized multifactor dimensionality reduction (GMDR) was used to analyze the gene-environment interaction; cross-validation consistency, the testing balanced accuracy, and the sign test to assess each selected interaction were calculated. The cross-validation consistency score is a measure of the degree of consistency with which the selected interaction is identified as the best model among all possibilities considered. The testing balanced accuracy is a measure of the degree to which the interaction accurately predicts case-control status with scores between 0.50 (indicating that the model predicts no better than chance) and 1.00 (indicating perfect prediction). Finally, a sign test or a permutation test (providing empirical *P* values) for prediction accuracy can be used to measure the significance of an identified model.

3. Results {#sec3}
==========

Distribution of the different demographic characteristics in groups of SLE patients (cases) and normal people (controls) was shown in [Table 2](#tab2){ref-type="table"}. The study population is Han people consisting of 421 SLE patients (137 males and 284 females, 49.8 ± 11.7 years old) and 425 control subjects (135 males and 290 females, 48.6 ± 10.9 years old), and there was *P* \> 0.05 in age between the two groups (*P* = 0.199). No significant difference was observed in the parameters including gender, age, BMI, and drinking rates between the two groups (*P* \> 0.05). But the current smoking rate was statistically higher in cases than in controls (*P* \< 0.05).

In our study, genotype frequencies of these four SNPs in the control group were in line with those expected under the Hardy-Weinberg equilibrium (*P* \> 0.05). The frequency for the *rs1929992-G* allele was 30.3% in patients, which was significantly higher than that of 19.8% in controls (*P* \< 0.05). The frequency for the *rs1891385-C* allele was 31.1% in cases, which was also significantly higher than that of 20.9% in controls (*P* \< 0.05). Logistic regression analysis showed that both the *rs1929992-G* and *rs1891385-C* alleles were related with an enhancing risk of SLE, the ORs (95% CI) of which were 1.62 (1.21-2.05) and 1.64 (1.22-2.10), respectively ([Table 3](#tab3){ref-type="table"}).

High-order interactions were investigated for SLE using the GMDR method. The data in [Table 4](#tab4){ref-type="table"} showed that one two-locus model (*rs1929992*×current smoking) had a testing accuracy of 60.11% (*P* = 0.001). Moreover, the analysis indicated that current smoking status influenced the SLE risk depending on the genotypes at *rs1929992*.

The result of pairwise LD analysis on four SNPs exhibited that *rs1929992* and rs7044343 within the IL-33 gene were in heavy LD (*D*′ value \> 0.75). Haplotype analysis by SHEsis software demonstrated that the haplotype *rs1929992A-*rs7044343C was observed with high frequencies in the two groups, which were 49.47% in the SLE patients and 55.75% in the controls, respectively. The results also indicated that haplotype rs1929992G-rs7044343T was significantly related with the growing risk of SLE ([Table 5](#tab5){ref-type="table"}). Those subjects with the G-T haplotype had a higher SLE risk than those with other haplotypes; after factors including age, BMI, current smoking, gender, and alcohol drinking were excluded.

4. Discussion {#sec4}
=============

In our study, we showed that both the *rs1929992-G* and *rs1891385-C* alleles were correlated to the risk of SLE and presented as potential risk factors for developing SLE. However, there was no relationship of rs7044343 and rs10975498 with SLE. Interleukin-33 (IL-33), encoded by the IL-33 gene, functions as a unique cytokine that may induce severe pathological changes and potentially lead to chronic inflammation \[[@B15]\], cancer \[[@B16]\], Behçet\'s disease \[[@B17]\], and autoimmune disease \[[@B18], [@B19]\]. Li et al. \[[@B19]\] for the first time found the significance of IL-33 rs7044343 in the development of RA, while the CC genotype of rs7044343 has been linked to the downregulation of serum IL-33 levels. These findings suggested that IL-33 contributed to the pathogenesis of RA. Recently, IL-22 SNPs are reported to be involved in systemic sclerosis and rheumatoid arthritis \[[@B20], [@B21]\]. Xu et al. \[[@B22]\] in a case-control study revealed that IL-33 rs1929992 was associated with SLE susceptibility according to the result from 371 SLE patients and 408 healthy controls among Chinese Han population. However, they also suggested that, in order to clearly explore the detailed role of this gene on IL-33 expression and the susceptibility to SLE, further functional analysis and the independent case-control study within a large amount of samples from distinct ethnical populations requires to be further conducted, which may eliminate the bias of interaction effect on the current results. In terms of rs1891385, another finding based on 257 SLE patients and 283 healthy controls in the Chinese population showed that rs1891385A/C polymorphism of IL-33 was one of the critical factors affecting the risk of SLE \[[@B23]\]. Importantly, the rs1891385C allele resulted in the higher risk of SLE than rs1891385-A allele did.

Basically, the pathogenesis of SLE is appreciated to be a complicated process, which is associated to environmental and genetic factors \[[@B13]\]. Some studies suggested that smoking may increase the risk of SLE \[[@B24], [@B25]\], while accumulative evidence shed light on the influence of gene-smoking interaction on SLE \[[@B26], [@B27]\]. Kiyohara et al. \[[@B26]\] reported that the relation between cigarette smoking and SLE varied due to genetic factors among female Japanese subjects. Our initial evidence demonstrated the impact of IL-33 and current smoking interaction on SLE risk in the Chinese population. The results also indicated that haplotype rs1929992G-rs7044343T may exert as a major determinant to the growing risk of SLE. Those subjects with the G-T haplotype had a higher SLE risk than those with other haplotypes, after correction for BMI, alcohol drinking, current smoking, gender, and age. However, the limitation in our study still existed; extra environmental factors as well as the interactions with SNPs ought to be further identified. In conclusion, our data demonstrated that the rs1929992-G and rs1891385-C alleles, interaction between the rs1929992 gene and current smoking, and haplotype rs1929992G-rs7044343T were all correlated to the rise of SLE risk.
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###### 

Description and primer sequences designed for sequencing 4 SNPs.

  SNPs                                          Chromosome   Major/minor alleles   Primer (5′→3′)
  --------------------------------------------- ------------ --------------------- -----------------------------------------------
  **rs1929992**                                 9:6251588    A/G                   Forward: 5′-CTTCTGCCCATTTGCAGCTGAT-3′
  Reverse: 5′-TCTTGAAGTCATSATCAACTTGGAACC-3′                                       
  rs7044343                                     9:6254208    C/T                   Forward: 5′-ACGTTGGATGTTGGGTGACACTATGAGTGG-3′
  Reverse: 5′-CAGGAAAGCTGATGCCCCAGTAT-3′                                           
  **rs1891385**                                 9:6219845    A/C                   Forward: 5′-CAAACAAGCAACAAAATCCCACTCA-3′
  Reverse: 5′-AATGGGACCTGACCCTGGACTT-3′                                            
  rs10975498                                    9:6226688    C/T                   Forward: 5′-CCATCTCTGTTCTAGCATCTCCTTCTACC-3′
  Reverse: 5′-AAGCCACAAAGCCTTTGTGTATTAGAAC-3′                                      

###### 

General characteristics of study participants in the case and control group.

  Variables                     SLE cases (*n* = 421)   Controls (*n* = 425)   *P* values
  ----------------------------- ----------------------- ---------------------- ------------
  Age (years) (means ± SD)      49.8 ± 11.7             48.6 ± 10.9            0.199
  Females, *N* (%)              284 (67.5)              290 (68.2)             0.809
  Current smoking, *N* (%)      128 (30.4)              80 (18.8)              0.000092
  Alcohol drinking, *N* (%)     142 (33.7)              155 (36.5)             0.404
  BMI (kg/m^2^) (means ± SD)    23.1 ± 7.4              23.9 ± 7.8             0.126
  Duration of disease (years)   5.8 (2.7-8.1)                                  
  SLEDAI                        15 (5-29)                                      

SLEDAI: Systemic Lupus Erythematosus Disease Activity Index.

###### 

Association analysis for 4 target SNPs within the IL-33 gene and SLE risk.

  SNPs            Genotypes or alleles   Frequencies *N* (%)   OR (95% CI)^∗^     HWE test for controls   
  --------------- ---------------------- --------------------- ------------------ ----------------------- -------
  **rs1929992**   AA genotype            277 (65.2)            209 (49.6)         1.00 (ref)              0.299
  AG genotype     128 (30.1)             169 (40.2)            1.51 (1.17-1.89)                           
  GG genotype     20 (4.7)               43 (10.2)             2.04 (1.34-2.78)                           
  A allele        682 (80.2)             587 (69.7)            1.00 (ref)                                 
  G allele        168 (19.8)             255 (30.3)            1.62 (1.21-2.05)                           
                                                                                                          
  rs7044343       CC genotype            244 (57.4)            220 (52.2)         1.00 (ref)              0.170
  CT genotype     149 (35.1)             159 (37.8)            1.26 (0.83-1.85)                           
  TT genotype     32 (7.5)               42 (10.0)             1.58 (0.76-2.42)                           
  C allele        637 (74.9)             599 (71.1)            1.00 (ref)                                 
  T allele        213 (25.1)             243 (28.9)            1.28 (0.81-2.01)                           
                                                                                                          
  **rs1891385**   AA genotype            270 (63.5)            201 (47.7)         1.00 (ref)              0.201
  AC genotype     132 (31.1)             172 (40.9)            1.51 (1.27-1.89)                           
  CC genotype     23 (5.4)               48 (11.4)             2.12 (1.43-2.88)                           
  A allele        672 (79.1)             580 (68.9)            1.00 (ref)                                 
  C allele        178 (20.9)             262 (31.1)            1.64 (1.22-2.10)                           
                                                                                                          
  rs10975498      CC genotype            249 (58.6)            224 (53.2)         1.00 (ref)              0.593
  CT genotype     150 (35.3)             162 (35.5)            1.25 (0.96-1.63)                           
  TT genotype     26 (6.1)               35 (8.3)              1.36 (0.89-1.88)                           
  C allele        648 (76.2)             610 (72.4)            1.00 (ref)                                 
  T allele        202 (23.8)             232 (27.6)            1.29 (0.95-1.69)                           

^∗^Adjusted for age, gender, BMI, current smoking, and alcohol drinking.

###### 

GMDR analysis for the best interaction combination models.

  Locus no.                               Best combination                                                   Cross-validation consistency   Testing accuracy   *P* values ^∗^
  --------------------------------------- ------------------------------------------------------------------ ------------------------------ ------------------ ----------------
  Gene-gene interactions^∗^                                                                                                                                    
  2                                       **rs1929992**×**rs1891385**                                        8/10                           0.5399             0.0547
  3                                       **rs1929992**×**rs1891385**×rs7044343                              9/10                           0.4958             0.1719
  4                                       **rs1929992**×**rs1891385**×rs7044343×rs10975498                   7/10                           0.4958             0.3770
  Gene-current smoking interactions^∗∗^                                                                                                                        
  2                                       **rs1929992**×current smoking                                      9/10                           0.6011             0.0010
  3                                       **rs1929992**×rs7044343×current smoking                            7/10                           0.5399             0.1719
  4                                       **rs1929992**×rs7044343×**rs1891385**×current smoking              6/10                           0.5399             0.3770
  5                                       **rs1929992**×rs7044343×**rs1891385**×rs10975498×current smoking   5/10                           0.4958             0.4258

^∗^Adjusted for age, gender, BMI, alcohol drinking, and current smoking. ^∗∗^Adjusted for age, gender, BMI, and alcohol drinking.

###### 

Haplotype analysis on association of the IL-33 gene and SLE risk.

  *Haplotypes* (**rs1929992** and rs7044343)   Frequencies   OR (95% CI)   *P* values^∗^      
  -------------------------------------------- ------------- ------------- ------------------ ---------
  A-C                                          0.4947        0.5575        1.00               ---
  A-T                                          0.2350        0.2273        1.31 (0.70-1.99)   0.481
  G-C                                          0.1984        0.1807        1.20 (0.65-1.93)   0.532
  G-T                                          0.0719        0.0345        1.65 (1.06-2.21)   \<0.001

^∗^Adjusted for gender, age, current smoking, alcohol drinking, and BMI.
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